COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,253 Articles (22,733 medRxiv, 8,520 bioRxiv)

Most recent first Previous |  Page 940: Articles 9391-9400  | Next

Multicenter Validation of a Machine Learning Algorithm for Diagnosing Pediatric Patients with Multisystem Inflammatory Syndrome and Kawasaki Disease
Lam, J. Y., Roberts, S. C., Shimizu, C., Bainto, E., Sivilay, N., Tremoulet, A. H., Gardiner, M. A., Kanegaye, J. T., Hogan, A. H., Salazar, J. C., Mohandas, S., Szmuszkovicz, J. R., Mahanta, S., Dionne, A., Newburger, J. W., Ansusinha, E., DeBiasi, R. L., Hao, S., Ling, X. B., Cohen, H. J., Nemati, S., Burns, J. C., Pediatric Emergency Medicine Kawasaki Disease Research Group, , CHARMS Study Group
10.1101/2022.02.07.21268280 — Posted: 2022-02-08
Factors associated with higher levels of grief and support needs among people bereaved during the pandemic: Results from a national online survey
Selman, L. E., Farnell, D. J., Longo, M., Goss, S., Torrens-Burton, A., Seddon, K., Mayland, C., Machin, L., Byrne, A., Harrop, E. J.
10.1101/2022.02.07.22270593 — Posted: 2022-02-08
Inequalities in mental and social wellbeing during the COVID-19 pandemic: prospective longitudinal observational study of five UK cohorts
Moreno-Agostino, D., Fisher, H. L., Hatch, S. L., Morgan, C., Ploubidis, G. B., Das-Munshi, J.
10.1101/2022.02.07.22270588 — Posted: 2022-02-08
Duration of protection of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 Omicron infection in Qatar
Chemaitelly, H., Ayoub, H. H., AlMukdad, S., Tang, P., Hasan, M. R., YASSINE, H. M., Al Khatib, H. A., Smatti, M. K., Coyle, P., Al Kanaani, Z., Al Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G., Al Kuwari, M. G., Butt, A. A., Al Romaihi, H. E., Al-Thani, M. H., Al Khal, A., Bertollini, R., Abu-Raddad, L. J.
10.1101/2022.02.07.22270568 — Posted: 2022-02-08
Time to reinfection and vaccine breakthrough SARS-CoV-2 infections: a retrospective cohort study
Molani, S., Baumgartner, A. M., Hwang, Y. M., Duvvuri, V. R., Goldman, J., Hadlock, J. J.
10.1101/2022.02.07.22270613 — Posted: 2022-02-08
Clinical outcomes in hospitalized vaccine-breakthrough COVID-19 cases compared with contemporary unvaccinated hospitalized adults
Wolff, M. J., Gilabert, M., Hernandez, R.
10.1101/2022.02.07.22270555 — Posted: 2022-02-08
COVID-19 excess death rate in Eastern European countries associated with weaker regulation implementation and lower vaccination coverage
Ylli, A., Burazeri, G., Wu, Y. Y., Sentell, T.
10.1101/2022.02.06.22270549 — Posted: 2022-02-08
SARS-CoV-2 infects, replicates, elevates angiotensin II and activates immune cells in human testes
Costa, G. M. J., Lacerda, S. M., Figueiredo, A. F. A., Wnuk, N. T., Brener, M. R., Campolina-Silva, G. H., Kauffmann-Zeh, A., Pacifico, L. G., Versiani, A. F., Andrade, L. M., Antunes, M. M., Souza, F. R., Cassali, G. D., Caldeira-Brant, A. L., Chiarini-Garcia, H., Costa, V. V., da Fonseca, F. G., Nogueira, M. L., Campos, G. R. F., Kangussu, L. M., Martins, E. M. N., Antonio, L. M., Bittar, C., Rahal, P., Aguiar, R. S., Mendes, B. P., Procopio, M. S., Furtado, T. P., Guimaraes, Y. L., Menezes, G. B., Martinez-Marchal, A., Brieno-Enriquez, M., Orwig, K. E., Furtado, M. H.
10.1101/2022.02.05.22270327 — Posted: 2022-02-08 Discussion: Offsite
Results from EDIFICE : A French pilot study on COVID-19 and the gut microbiome in a hospital environment
Cervino, A. C. L., Fabre, R., Plassais, J., Gbikpi-Benissan, G., Petat, E., Le Quellenec, E., Neuberger-Castillo, L., Laurent, J.-M., Iordache, L., Bouchahda, M., Marti, G., Chapelet, G.
10.1101/2022.02.06.22269945 — Posted: 2022-02-08
Increased household transmission and immune escape of the SARS-CoV-2 Omicron variant compared to the Delta variant: evidence from Norwegian contact tracing and vaccination data
Jalali, N., Brustad, H. K., Frigessi, A., MacDonald, E. A., Meijerink, H., Firuglio, S. L., Nygard, K. M., Ro, G. O. I., Madslien, E. H., de Blasio, B. F.
10.1101/2022.02.07.22270437 — Posted: 2022-02-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).